FDA Alert: Chantix (varenicline): Label Change - Risk of Certain Cardiovascular Adverse Events

Links shared publicly online about this topic.

  • 120
    total visits

FDA Alert: Chantix (varenicline): Label Change - Risk of Certain Cardiovascular Adverse Events

drugs.com

FDA Alert: Chantix (varenicline): Label Change - Risk of Certain Cardiovascular Adverse Events

View full resource at drugs.com

Tags: Heart, Smoking Cessation, Smoking Cessation Medication, FDA, Chantix, Event

  • Share

Most Recently Shared on July 25, 2011 at 8:29 pm By:

drugscom Drugs.com

FDA Alert - Label Change: Chantix (varenicline) - Risk of Certain Cardiovascular Adverse Events - http://bit.ly/oo8JO3

9 months ago...

Advertisement